Cargando…

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis

OBJECTIVE: To identify subsets of chronic obstructive pulmonary disease (COPD) patients who are more protected from exacerbations with the use of an inhaled corticosteroid/long-acting β(2) agonist (ICS/LABA) combination, compared with the use of LABA monotherapy. DESIGN: Post hoc cluster analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	DiSantostefano, Rachael L, Li, Hao, Rubin, David B, Stempel, David A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641457/ https://www.ncbi.nlm.nih.gov/pubmed/23613569 http://dx.doi.org/10.1136/bmjopen-2012-001838

Ejemplares similares

Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis
por: Hinds, David R, et al.
Publicado: (2016)

Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study
por: DiSantostefano, Rachael L., et al.
Publicado: (2014)

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2014)

Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)
por: Quint, Jennifer K, et al.
Publicado: (2014)

Correction to: Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis
por: El Baou, Céline, et al.
Publicado: (2017)

Impact of smoking status on the efficacy of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review
por: Sonnex, Kimberley, et al.
Publicado: (2020)

Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study
por: Björnsdóttir, U S, et al.
Publicado: (2014)

Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study
por: Tan, Wan C, et al.
Publicado: (2012)

Study protocol: pneumonia and inhaled corticosteroid treatment patterns in chronic obstructive pulmonary disease – a cohort study using sequence analysis (PICCS)
por: Klitgaard, Allan, et al.
Publicado: (2023)

Protocol for a systematic literature review and network meta-analysis of the clinical benefit of inhaled maintenance therapies in chronic obstructive pulmonary disease
por: Lewis, Adam, et al.
Publicado: (2019)

‘The blue one takes a battering’ why do young adults with asthma overuse bronchodilator inhalers? A qualitative study
por: Cole, Sue, et al.
Publicado: (2013)

The role of inhaled and/or nasal corticosteroids on the bronchodilator response
por: Lee, Ju Kyung, et al.
Publicado: (2010)

Latrophilin receptors: novel bronchodilator targets in asthma
por: Faiz, A, et al.
Publicado: (2017)

Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Axson, Eleanor L, et al.
Publicado: (2020)

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
por: Miravitlles, Marc, et al.
Publicado: (2022)

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β(2)-agonists for asthma maintenance treatment in Germany
por: Aballéa, S, et al.
Publicado: (2008)

Study of the burden on patients with chronic obstructive pulmonary disease
por: Izquierdo, J L, et al.
Publicado: (2009)

Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis
por: El Baou, Céline, et al.
Publicado: (2017)

Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis
por: Lokhandwala, Tasneem, et al.
Publicado: (2012)

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
por: Singh, Sonal, et al.
Publicado: (2010)

Ten-year prediction model for post-bronchodilator airflow obstruction and early detection of COPD: development and validation in two middle-aged population-based cohorts
por: Perret, Jennifer L, et al.
Publicado: (2021)

Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis
por: Morton, Miranda, et al.
Publicado: (2023)

Area Under the Expiratory Flow–Volume Curve (AEX): Assessing Bronchodilator Responsiveness
por: Ioachimescu, Octavian C., et al.
Publicado: (2020)

The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2016)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
por: Asche, Carl Victor, et al.
Publicado: (2012)

Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis
por: Tricco, Andrea C, et al.
Publicado: (2015)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trial
por: Li, Jie, et al.
Publicado: (2019)

Change in individual chronic obstructive pulmonary disease assessment test item scores after short-term bronchodilator therapy and its impact on exacerbation in treatment-naïve patients with chronic obstructive pulmonary disease
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Multicentre double-blind randomised controlled trial of systematic corticosteroid therapy in patients with acute exacerbations of chronic obstructive pulmonary disease admitted to hospital with higher eosinophil levels: the ECHO protocol
por: Liang, Lirong, et al.
Publicado: (2023)

Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre
por: Demarche, Sophie F, et al.
Publicado: (2017)

PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population
por: Criner, Gerard, et al.
Publicado: (2023)

Implementing a choice of pulmonary rehabilitation models in chronic obstructive pulmonary disease (HomeBase2 trial): protocol for a cluster randomised controlled trial
por: Holland, Anne E, et al.
Publicado: (2022)

Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial
por: Hua, Jianlan, et al.
Publicado: (2020)

Chemical exposure and alveolar macrophages responses: ‘the role of pulmonary defense mechanism in inhalation injuries’
por: Tapak, Mahtab, et al.
Publicado: (2023)

Impact of corticosteroids in hospitalised COVID-19 patients
por: Ho, Kam Sing, et al.
Publicado: (2021)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

Determinants of poor inhaler technique and poor therapy adherence in obstructive lung diseases: a cross-sectional study in community pharmacies
por: Vanoverschelde, Anna, et al.
Publicado: (2021)

Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007)

Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilators
por: Hendrickx, Ramon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t8uglqd0ahcp943n7m1o6sdjrj